ArticleJournal of advanced research2024

CRISPR/Cas9-mediated neuronal deletion of 5-lipoxygenase alleviates deficits in mouse models of epilepsy.

Qiwen Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.